NEW YORK (GenomeWeb News) — Farfield Scientific will partner with Australia’s Monash University to develop biosensor surfaces to analyze protein functioning, UK-based Farfield said today.
The company said the aim of the collaboration, which has received funding from the Australian Research Council, is to commercialize membrane-mimetic biosensor surfaces to analyze the structure and functioning of membrane-associating peptides and proteins.
Monash project leader Mari-Isabel Aquilar said the collaboration with the school’s Department of Biochemistry and Molecular Biology will use Farfield’s AnaLight Bio2000 Dual Polarization Interferometry tool to analyze membrane surfaces, and develop and apply biosensor chips based on Monash’s IP for identifying new proteins and drug targets.
Farfield CEO Gerry Ronan said the research will create a bioanalytical toolkit that will “ultimately lead to an entirely new approach to structurally informed drug discovery.”